Common Contracts

EX-10.1 2 d409692dex101.htm EX-10.1 EXECUTION VERSION [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF...

Termination Agreement • May 5th, 2020 • New York

• Contract Type
  Termination Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

THIS TERMINATION AGREEMENT (this “Termination Agreement”) is made and entered into effective as of the Termination Effective Date by and between IMMUNOMEDICS, INC., a Delaware corporation (“IMMU”), and SEATTLE GENETICS, INC., a Delaware corporation (“SGEN”). Each of IMMU and SGEN may be referenced herein individually as a “Party” and collectively as the “Parties”.

TERMINATION AGREEMENT

Termination Agreement • August 1st, 2017 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York

• Contract Type
  Termination Agreement
• Filed
  August 1st, 2017
• Company
  Seattle Genetics Inc /Wa
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS TERMINATION AGREEMENT (this “Termination Agreement”) is made and entered into effective as of the Termination Effective Date by and between IMMUNOMEDICS, INC., a Delaware corporation (“IMMU”), and SEATTLE GENETICS, INC., a Delaware corporation (“SGEN”). Each of IMMU and SGEN may be referenced herein individually as a “Party” and collectively as the “Parties”.